Eventually, the scientists came close to the time when about half of the fatal cancer diseases will become curable. About the flagships of the "cancer of revolution" – in our review.
Interesting experiments with light, nanomaterials and technologies for genetic engineering.
In addition, the success of modern Oncology, largely is the success of diagnostics and prophylaxis, and as treatment becomes more individual, there is a direct connection between breakthroughs in therapy and personalized medicine in General.
In the 21st century world, became the first drugs acupressure on the immune system (ipilimumab, rituximab, pembrolizumab). All of them, not surprisingly, imported. At the end of 2016, the leading international pharmaceutical signed a Memorandum of cooperation and the development of immunology in Russia.
The next day the MSD (the maker of ambrosianae) has registered Russia's first drug from the class of inhibitors of PD-1/PD-L1. This is a specific antibody (the so-called "monoclonal antibody"), it inhibits protein programmed cell death that hides metastases from the immune system.
Pembrolizumab is unique in that it eliminates the running or recurrent tumors, inoperable melanoma or lung cancer. It is expected to reach patients by mid-2017.
By the end of 2016 has brought the national Oncology another big event. RAS scientists synthesized a new compound of sulphur, hydrocarbons and nitrogen. It will help where powerless chemotherapy (for example carcinoma of the ovary). The method of synthesis allows to quickly obtain anti-cancer drugs at low cost: the creators brought a few dozen drugs at once.
Another international success is a complete exploration of viruses. By the beginning of the year in the United States approved the first anti-cancer agent on the basis of the herpes virus. Since the drug firmly established as the market and the top ranking medical innovations version of the Popular Science.
Finally, American scientists have made a "hormonal breakout": prostate cancer was first cured with an injection of testosterone. In the blood of volunteers has fallen dramatically the level of "prostate specific antigen" (by the way, an effective tumor marker). One patient and completely gets rid of the antigen — thus, fully recovered from cancer just three months.
Despite the results, the method has not yet passed a number of clinical trials and remains "experimental": however, for patients this means more indirect problems (e.g. design documents), but not a direct threat or illegal treatment.
Diagnosis and prevention: cancer cancer
In addition, a special status for the modern diagnosis of lung cancer. Now the best way to detect it proactively scan the groups of active smokers with great experience. And here a fresh study showed that the risk of death from lung cancer is almost two times reduced by taking ibuprofen. This is an argument of statistics in favor of the respective prevention.
Robots and bacteria as cutting-edge experimental methods
Promising areas — work with nanoparticles that deliver the drug inside the cancer cell.
Another option — point input of nanorobots, as well suitable for monitoring and for drug delivery, and even direct attack on the tumor and its metastases.
Last summer in the Moscow state University have substantiated the therapeutic value of silicon nanoparticles. The reason was their ability to rapidly decompose, not accumulating inside the body extra weight: this makes them great in terms of medical transportation.
In another famous University, Stanford, investigated the iron nanoparticles: a substance formed by them ferumoxytol well as charges the immune system to fight metastases.
Meanwhile, scientists from Canada have turned flagellated bacteria in nankobogo high precision.
It is also actively developing therapy anaerobic bacteria: they are easy to destroy the Central part of the tumor and are perfectly complemented by chemotherapy.